Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment.

作者: Carlos Ramirez , Inmaculada Tercero , Antonia Pineda , Javier S. Burgos

DOI: 10.3233/JAD-2010-101653

关键词:

摘要: Statins have recently been shown to act as protectants against several neuropathological conditions. They received special attention in the field of Alzheimer's disease (AD), where epidemiological studies indicating a lower prevalence AD/dementia statin-prescribed populations. Excitotoxicity, which derives from overstimulation glutamate receptors, is major cause neuron death neurological diseases, including AD and epilepsy. We carried out comparative study investigate effects all commercially available statins (simvastatin, lovastatin, fluvastatin, pravastatin, atorvastatin) on damage memory impairment. To this end, we studied neurodegeneration mouse model by systemic administration kainate. Simvastatin was most effective statin reducing deleterious caused kainate, severity seizures, excitotoxicity, oxidative damage, neuritic dystrophy apoptosis hippocampus other limbic structures brain cortex. Lovastatin second efficient preventing seizures histopathological signs whilst atorvastatin showed neither antiepileptic nor neuroprotective effects. Only simvastatin enhanced episodic-like memory. best our knowledge first vivo analyze effect statins. Our results suggest that both lovastatin (but especially simvastatin) may well therapeutic potential treatment neurodegenerative diseases involving excitotoxicity impairment, AD.

参考文章(49)
George Paxinos, Keith B. J. Franklin, The Mouse Brain in Stereotaxic Coordinates ,(2007)
Saleta Sierra, Maria C. Ramos, Pilar Molina, Cynthia Esteo, Jose Antonio Vázquez, Javier S. Burgos, Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death. Journal of Alzheimer's Disease. ,vol. 23, pp. 307- 318 ,(2011) , 10.3233/JAD-2010-101179
Milos Pekny, Ulrika Wilhelmsson, Yalda Rahpeymai Bogestål, Marcela Pekna, The role of astrocytes and complement system in neural plasticity. International Review of Neurobiology. ,vol. 82, pp. 95- 111 ,(2007) , 10.1016/S0074-7742(07)82005-8
Ana Catarina R.G. Fonseca, Teresa Proença, Rosa Resende, Catarina R. Oliveira, Cláudia M.F. Pereira, Neuroprotective Effects of Statins in an In Vitro Model of Alzheimer's Disease Journal of Alzheimer's Disease. ,vol. 17, pp. 503- 517 ,(2009) , 10.3233/JAD-2009-1067
A. Frick, W. Zieglgänsberger, H.-U. Dodt, Glutamate receptors form hot spots on apical dendrites of neocortical pyramidal neurons. Journal of Neurophysiology. ,vol. 86, pp. 1412- 1421 ,(2001) , 10.1152/JN.2001.86.3.1412
Zu-lin Chen, Justin A. Indyk, Thomas H. Bugge, Keith W. Kombrinck, Jay L. Degen, Sidney Strickland, Neuronal Death and Blood–Brain Barrier Breakdown after Excitotoxic Injury Are Independent Processes The Journal of Neuroscience. ,vol. 19, pp. 9813- 9820 ,(1999) , 10.1523/JNEUROSCI.19-22-09813.1999
Keri J Hopkins, Guang-Jian Wang, Larry C Schmued, Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain Brain Research. ,vol. 864, pp. 69- 80 ,(2000) , 10.1016/S0006-8993(00)02137-5
Takeshi Hayashi, Keiko Hamakawa, Shoko Nagotani, Guang Jin, Feng Li, Kentaro Deguchi, Yoshihide Sehara, Hanzhe Zhang, Isao Nagano, Mikio Shoji, Koji Abe, HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons Brain Research. ,vol. 1037, pp. 52- 58 ,(2005) , 10.1016/J.BRAINRES.2004.12.051
Marwan N. Sabbagh, Kabir Thind, David Larry Sparks, On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks. Alzheimer Disease & Associated Disorders. ,vol. 23, pp. 303- 305 ,(2009) , 10.1097/WAD.0B013E3181A80242